leadf
logo-loader
NASDAQ:ADMS

Adamas Pharmaceuticals Inc

Receive alerts
Market:
NASDAQ
Market Cap:
$134.62 m
Price
4.76 USD
Change
3.25%
52 weeks high
7.77
52 weeks low
1.91

In brief

Headquartered in Emeryville, California, Adamas Pharmaceuticals develops and sells therapies for chronic neurologic disorders. The company's approved/commercial product is GOCOVRI, an amantadine therapy for the treatment of levodopa-induced dyskinesia in patients with Parkinson's disease.